Extendicare Inc faced a setback in its stock performance, dropping over 2% in yesterday's trading session.
Extendicare Inc (EXE.TO) experienced a decline of 2.06% in its stock price yesterday, closing at CA$34.19. This drop comes amid a broader market environment where investors are closely monitoring the health care sector's performance.
Advertisement
Extendicare Inc
EXE.TO
EXE.TO
Extendicare Inc
WealthAwesomeMarket cap
$3.31B
P/E
25.7x
Div. yield
1.47%
Div. / share
$0.51
52W high
$39.09
52W low
$12.39
1W change
-6.07%
Beta
1.16
Analyst Price Targets
Based on analyst covering EXE
Wall Street analysts forecast EXE stock price to rise 13.6% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$38.83
+13.6% Upside
Current Price
C$34.19
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EXE's historical volatility
30-Day Vol
30.7%
Annualized
90-Day Vol
34.4%
Annualized
Trend (90d)
+30.3%
Annualized drift
90d Mean
C$38.10
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$35.45 | C$31.89 – C$39.40 |
| 60 trading days | C$36.75 | C$31.64 – C$42.68 |
| 90 trading days | C$38.10 | C$31.72 – C$45.76 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious as Extendicare's recent performance indicates potential volatility in the stock, despite its solid market fundamentals.
Bull case
Extendicare has shown resilience in its business model, particularly with strong growth in home health care services. The recent increase in its dividend could attract long-term investors looking for stability and income.
Bear case
The recent decline in stock price raises concerns about investor confidence, especially with potential market headwinds affecting the health care sector. This drop might make some investors wary about the company's future performance.
Market Reaction
The 2.06% decline in Extendicare's stock price reflects a cautious sentiment among investors. With a market cap of CA$3.31 billion, this decrease could indicate underlying concerns about the company's ability to navigate the competitive health care landscape.
Advertisement
Investor Sentiment
Yesterday's drop may prompt investors to reassess their positions in Extendicare. While the company has shown growth potential, especially in home health care, the recent performance suggests that market confidence may be wavering. Investors should keep an eye on upcoming earnings reports and market trends that could influence stock performance.
Looking Ahead
As Extendicare continues to expand its services and adapt to market demands, investors will need to weigh the risks against potential rewards. The company's recent dividend increase could be a positive signal, but the stock's recent decline highlights the importance of vigilance in the current market environment.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
